https://www.selleckchem.com/pr....oducts/alofanib-rpt8
Furthermore, a representative α-ketoamide derivative was tested and found to be active in inhibiting the cellular infection of SARS-CoV-2 which causes the COVID-19 pandemic. These results demonstrate that this new class of α-ketoamide derivatives are potent anticancer agents and provide experimental evidence of the anti-SARS-CoV-2 effect by one of them, thus suggesting a possible new lead to develop antiviral therapeutics for COVID-19.Prior modification of betulinic acid (1), a natural product lead with promising anti-HIV activi
Like
Comment
Share
